Authors
Latest:
Improvement of Structural Profiling of N-glycans in BiologicsA suitable tool for analyzing glycans in biopharmaceutical manufacturing is the growing use of analytical enzymes known as exoglycosidases.
Latest:
Improvement of Structural Profiling of N-glycans in BiologicsA suitable tool for analyzing glycans in biopharmaceutical manufacturing is the growing use of analytical enzymes known as exoglycosidases.
Latest:
Improvement of Structural Profiling of N-glycans in BiologicsA suitable tool for analyzing glycans in biopharmaceutical manufacturing is the growing use of analytical enzymes known as exoglycosidases.
Latest:
Improvement of Structural Profiling of N-glycans in BiologicsA suitable tool for analyzing glycans in biopharmaceutical manufacturing is the growing use of analytical enzymes known as exoglycosidases.
Latest:
Understanding Internal Release LimitsInternal release limits help ensure that a batch of drug product remains within specifications throughout its shelf life. This article explores what internal release limits are and why they are important.
Latest:
Using Nondestructive in-situ Measurements to Ensure Lyophilized Product StabilityNon-destructive surface area measurement can improve stability testing.
Latest:
Understanding Internal Release LimitsInternal release limits help ensure that a batch of drug product remains within specifications throughout its shelf life. This article explores what internal release limits are and why they are important.
Latest:
Understanding Internal Release LimitsInternal release limits help ensure that a batch of drug product remains within specifications throughout its shelf life. This article explores what internal release limits are and why they are important.
Latest:
Understanding Internal Release LimitsInternal release limits help ensure that a batch of drug product remains within specifications throughout its shelf life. This article explores what internal release limits are and why they are important.
Latest:
Perspectives in MicroRNA TherapeuticsThe authors provide further insight into microRNA biology, and the simplicity of anti-miR oligonucleotide drug delivery.
Latest:
Transformations in Drug Development for Cell and Gene TherapiesAs a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Latest:
Strategies for Managing the Impact of Brexit for US Biotech CompaniesThis article explores major aspects for United States biotech companies to consider when creating a compliant post-Brexit strategy.
Latest:
Mucoadhesion GuideLooking to improve drug product effectiveness and differentiate? Mucoadhesion – the ability of a formulation to adhere to a mucous membrane – is an attractive option for those keen to ensure their products stand out in a crowded market.
Latest:
Improving Your mAb Purification• WorkBeads™ 40 TREN is an excellent tool as a guard column upstream protein A resins • WorkBeads 40 TREN removes ~99% of HCD, reduces HCP ~3-fold & removes >93% of endotoxins WorkBeads affimAb in a single step gives a 10-fold more pure mAb eluate than MaSelect SuRe™
Latest:
Protecting Drug SafetyIn the past 10 years, safety issues have become increasingly important in pharmaceutical packaging, from needle sticking safety to counterfeit protection.
Latest:
Accelerating Biosimilar AnalysisMass spectrometry should be utilized effectively to optimize biosimilar analysis, which can reduce development time and cost.
Latest:
Challenges In The Changing Outsourcing LandscapeOriol Prat, Marketing Manager, and Marga Viñes Senior Product Manager, from Grifols give us a quick rundown of how business is changing and what challenges the company faces.
Latest:
Enterprise Resource Planning Systems Provide Supply Chain TraceabilityAn ERP solution provides for the management of multiple business activities and traceability requirements resulting from regulations, customer demands, sourcing, and international business needs.
Latest:
Industry Outlook 2025: Technology as a Supporting ElementPharmaceutical Technology® spoke with Alexander Seyf, CEO and co-founder of Autolomous, about the use of artificial intelligence and machine learning in pharmaceutical development and manufacturing.
Latest:
Design Space Characterization and Risk Assessment Through Mechanistic ModelingMechanistic process and product modeling turns data into knowledge that can be extrapolated with known confidence for design space characterization and risk assessment.
Latest:
Design Space Characterization and Risk Assessment Through Mechanistic ModelingMechanistic process and product modeling turns data into knowledge that can be extrapolated with known confidence for design space characterization and risk assessment.
Latest:
Quality by Design: A CMO's Perspective on Gaining Knowledge Faster and BetterTraditional project decision-making is compared with a QbD approach.
Latest:
Determining Water Content with a Novel Karl Fischer Titration ApproachA new approach to testing water content in biologics is needed that will give a more accurate determination of actual water content in the biologic.
Latest:
The Impact of Vortexing on the Particle-Size Distribution of PharmaceuticalsIf a vortex mixer produces too much energy during sample preparation for particle size analysis, the size and morphology of particles can change. A study compares the applied shear to sample suspensions of ibuprofen to observe the effects of applied shear on the particle size distribution.
Latest:
The Impact of Vortexing on the Particle-Size Distribution of PharmaceuticalsIf a vortex mixer produces too much energy during sample preparation for particle size analysis, the size and morphology of particles can change. A study compares the applied shear to sample suspensions of ibuprofen to observe the effects of applied shear on the particle size distribution.
Latest:
Managing Hazardous Waste from Pharma ProcessesPharmaceutical manufacturers must stay compliant with changing regulations for hazardous waste disposal.
Latest:
Best Practices in Analytical Method Development and TestingThis article discusses why it is important to apply risk analysis, QbD, and DoE in the development of analytical methods.
Latest:
Microbiology & toxicology testing services for the medical device and pharmaceutical industries.Wickham Laboratories Ltd is a trusted name in the pharmaceutical and medical device industries with over 50 years of experience in contract testing, research and consultancy.
